Phase II Study of Temozolomide in Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)
Latest Information Update: 21 Apr 2023
At a glance
- Drugs Temozolomide (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 15 Jan 2013 New trial record